Tenable Announces Second Quarter 2020 Financial Results
Added 341 new enterprise platform customers and 50 net new six-figure customersRevenue of $107.2 million, up 26% year-over-yearGAAP loss from […]
eXp World Holdings to Announce Second-quarter 2020 Results August 5, Host Virtual Investor Q&A August 6
BELLINGHAM, Wash., July 28, 2020 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: EXPI), the holding company for eXp Realty […]
Denny’s Corporation Reports Results For Second Quarter 2020
SPARTANBURG, S.C., July 28, 2020 (GLOBE NEWSWIRE) — Denny’s Corporation (NASDAQ: DENN), franchisor and operator of one of America’s largest […]
Otonomy to Report Second Quarter 2020 Financial Results and Provide Corporate Update
SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) — Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative […]
ADDvantage Technologies Group to Report Fiscal 2020 Third Quarter Financial Results on August 11, 2020
CARROLLTON, Texas, July 28, 2020 (GLOBE NEWSWIRE) — ADDvantage Technologies Group, Inc. (NASDAQ: AEY) (“ADDvantage Technologies” or the “Company”) today […]
Kornit Digital Announces Date for Second Quarter 2020 Earnings Results
ROSH HA’AYIN, Israel, July 28, 2020 (GLOBE NEWSWIRE) — Kornit Digital (Nasdaq: KRNT), a worldwide market leader in digital textile […]
Amedisys Reports Second Quarter 2020 Financial Results – Reissues 2020 Guidance
BATON ROUGE, La., July 28, 2020 (GLOBE NEWSWIRE) — Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the […]
Mondelēz International Reports Q2 2020 Results
Net revenues decreased 2.5% primarily driven by unfavorable currency impacts, with Organic Net Revenue1 growth of 0.7% and incremental net […]
T2 Biosystems to Report Second Quarter 2020 Financial Results on August 11, 2020
LEXINGTON, Mass., July 28, 2020 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, […]
Annexon Announces Closing of Initial Public Offering
SOUTH SAN FRANCISCO, Calif., July 28, 2020 (GLOBE NEWSWIRE) — Annexon, Inc. (Nasdaq: ANNX), a clinical-stage biopharmaceutical company developing a […]
